TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetAdenosine receptor A1(Rattus norvegicus (rat))
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 0.282nMAssay Description:Adenosine A1 receptor binding using [3H]DPCPX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(RAT)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetAdenosine receptor A1(Homo sapiens (Human))
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 0.490nMAssay Description:Adenosine A1 receptor binding using [3H]DPCPX in human cortical membranesMore data for this Ligand-Target Pair
TargetAdenosine receptor A1(Rattus norvegicus (rat))
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 0.490nMAssay Description:Adenosine A1 receptor binding using [3H]DPCOX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetAdenosine receptor A1(Rattus norvegicus (rat))
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 6.60nMAssay Description:Adenosine A1 receptor using [3H]DPCOX in rat cortical membranesMore data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 70nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 110nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a/A2b(Rattus norvegicus)
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 151nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 156nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 164nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 204nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 287nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(RAT)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 440nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 500nMAssay Description:Displacement of FITC-labelled SP2 probe from human TIM-3 IgV domain (residues 22 to 130) expressed in Escherichia coli BL21 (DE3) by FPA competition ...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 550nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 750nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 970nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a/A2b(Rattus norvegicus)
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 1.20E+3nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
TargetAdenosine receptor A2a/A2b(Rattus norvegicus)
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Fujisawa Pharmaceutical Company, Ltd.
Curated by ChEMBL
Affinity DataKi: 1.26E+3nMAssay Description:Adenosine A2 receptor binding using [3H]CGS-21680 in rat striatal membranesMore data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 1.30E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 1.50E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 1.60E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 1.80E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 2.10E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 2.20E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 2.30E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 2.60E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetHepatitis A virus cellular receptor 2(Homo sapiens)
Vanderbilt University School of Medicine
Curated by ChEMBL
Vanderbilt University School of Medicine
Curated by ChEMBL
Affinity DataKi: 4.90E+3nMAssay Description:Displacement of FITC-labelled 5-(((8-Chloro-9-(3-methylpyridin-4-yl)-5-oxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-2-yl)methyl)carbamoyl)-2-(6-h...More data for this Ligand-Target Pair
TargetGastrin/cholecystokinin type B receptor(GUINEA PIG)
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
Fujisawa Pharmaceutical Co., Ltd
Curated by PDSP Ki Database
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.180nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.190nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.200nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.260nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.290nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.300nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.310nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.320nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.370nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.370nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.490nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Rattus norvegicus (rat))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.530nMAssay Description:Inhibition of DPP4 in rat plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
Affinity DataIC50: 0.560nMAssay Description:Inhibition of adenosine induced negative inotropic activity against guinea-pig atria (Adenosine A1 receptor)More data for this Ligand-Target Pair
TargetDipeptidyl peptidase 4(Homo sapiens (Human))
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Mitsubishi Tanabe Pharma Corporation
Curated by ChEMBL
Affinity DataIC50: 0.620nMAssay Description:Inhibition of DPP4 in human plasma using GLY-Pro-MCA as substrate after 60 mins by fluorescence assayMore data for this Ligand-Target Pair
